ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.46
0.22%
US Tech 100
18,690.80
0.93%
S&P 500
5,473.21
0.26%
US Dollar vs CAD
1.38464
0.12%
Bitcoin
68,924.90
1.66%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. TetraLogic Pharmaceuticals Corporation (CE) (TLOG)

  7. TetraLogic Pharmaceuticals Corporation (CE) (TLOG) News

TLOG

TetraLogic Pharmaceuticals (CE) (TLOG)

TetraLogic Pharmaceuticals Corporation (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:TLOG
DateTimeSourceHeadlineSymbolCompany
02/16/20215:30AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/15/20192:51PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
06/27/20183:26PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/19/20173:48PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/18/20175:05AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
08/30/20175:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
08/17/20173:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
08/04/20172:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/03/20164:29PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/03/20164:29PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/03/20164:27PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/03/201612:13PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/03/201612:11PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
11/02/20163:30PMGlobeNewswire Inc.TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible ...USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
10/19/20163:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/06/20163:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/01/20163:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
08/11/201612:24PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
07/22/20163:19PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
07/20/20163:21PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
06/15/20163:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
05/09/20161:41PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
05/04/201612:32PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
04/28/20165:21AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
04/28/20165:18AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
04/07/20163:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/16/20164:19PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/16/201612:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/10/20162:48PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/10/20161:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
 Showing the most relevant articles for your search:USOTC:TLOG

Your Recent History

USOTC
TLOG
TetraLogic Pharmaceuticals (CE)
BIT
F15427
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved